Cargando…
SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1
BACKGROUND: Cancer stem cells (CSCs) have been recognized as an important drug target, however, the underlying mechanisms have not been fully understood. SKP1 is a traditional drug target for cancer therapy, while, whether SKP1 promotes colorectal cancer (CRC) stem cells (CRC-SCs) and the underlying...
Autores principales: | Tian, Cong, Lang, Tingyuan, Qiu, Jiangfeng, Han, Kun, Zhou, Lei, Min, Daliu, Zhang, Zhiqi, Qi, Dachuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713163/ https://www.ncbi.nlm.nih.gov/pubmed/33292299 http://dx.doi.org/10.1186/s12935-020-01683-0 |
Ejemplares similares
-
PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway
por: Gu, Jiayi, et al.
Publicado: (2019) -
Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics
por: Han, Kun, et al.
Publicado: (2018) -
Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020) -
RASSF-1A modulates proliferation-mediated oral squamous cell carcinoma progression
por: Sun, Jianli
Publicado: (2019) -
Baicalin Attenuates YAP Activity to Suppress Ovarian Cancer Stemness
por: Li, Yucong, et al.
Publicado: (2020)